Biologics In Focus

Introduction

Welcome to the June edition of Biologics In Focus, Lonza’s monthly biologics newsletter.

Each month, we deliver deep analysis of industry trends, expert insights, and an overview of upcoming events—as well as the latest Lonza news and real-world customer stories.

If you enjoyed reading this month’s newsletter, why not join the 80,000 people who have already subscribed and ensure you don’t miss any future editions?

Lonza News and Updates

New fast-track tech transfer offering

Lonza has launched an accelerated tech transfer program for clinical biologics drug products. This program enables seamless clinical tech transfers and the first GMP-released clinical batch, either as a liquid or lyo product in vials, in as little as five months. Find out more about it here.

Insights and Analysis

Webinar: Navigating your Holistic Approach to Container Closure Integrity for Biologic Drug Products

Earlier this month, Lonza’s Jean-Sebastien Steffen and Fred Bathke ran a webinar and gave an overview of the regulatory framework and expectations for tightly closed, aseptically filled parenteral drug products and showcased the practical activities occurring from the early stages to the product launch and beyond. You can now watch it on demand here.

Simplifying the Encapsulation Process of Nucleic Acid Payloads

mRNA therapies are currently developed for the prevention and treatment of various diseases, ranging from infectious diseases to cancers and genetic disorders. However, the transition from pre-clinical development to commercial manufacturing poses several challenges, particularly in achieving consistent and scalable encapsulation processes.

Lonza joined forces with two Engineering experts, FDX Fluid Dynamix (FDX) and the Fraunhofer Institute for Production Systems and Design Technology IPK, to advance the encapsulation efficiency of mRNA-based therapies. You can find out more about the collaboration and the benefits here.

Lonza in the Press

Speeding Up Aseptic Processes

Peter Droc and Belinda Holdsworth sat down with BioPharm International to discuss which technological advances are impacting current aseptic processes and improving time-to-market. Learn more in the article here.??

Customer Case Study

Levicept shares its experience building a successful relationship with Lonza

Levicept Founder and CEO Simon Westbrook discusses how the company identified Lonza as the right CDMO partner to develop LEVI-04 after two failed attempts with previous CDMOs.

Find out more about how they built a strong relationship with the team to overcome development hurdles and achieve accelerated timelines.

Upcoming Events

Presentation:

July 10, 1.20pm, Conference Room #318: Optimising the Path to First-in-Human Clinical Trials: An Integrated Approach to Design and De-risk Your Candidate, Including ADCs

Upcoming Webinars

Monday 8th July. 11am EDT | 5pm CET Register here

Accelerating Drug Development For Biologics

Thursday 11th July. 11am EDT | 5pm CET Register here

Tech transfer strategies and best practices to optimize your clinical and commercial supply

Thank you as ever for reading. If you haven't already, remember to subscribe so you never miss our monthly updates.

If you'd like to find out more about Lonza Biologics, you can visit our website here or contact one of our team of experts here